The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Ferring; ipsen; Janssen-Cilag; Sanofi
Consulting or Advisory Role - Astellas Pharma; Bayer; Ferring; Janssen-Cilag; Sanofi
Speakers' Bureau - Astellas Pharma; Astellas Pharma; Janssen-Cilag; Janssen-Cilag
Research Funding - AstraZeneca (Inst)
Travel, Accommodations, Expenses - Multiple Companies as set out above
Adding abiraterone for men with high-risk prostate cancer (PCa) starting long-term androgen deprivation therapy (ADT): Survival results from STAMPEDE (NCT00268476).
 
Nicholas D. James
Honoraria - Astellas Pharma; Bayer; Janssen; Oncogenex; Pierre Fabre; Sanofi
Consulting or Advisory Role - Astellas Pharma; Bayer; Janssen; Merck; Sanofi
Speakers' Bureau - Astellas Pharma; Ferring; Pierre Fabre; Sanofi
Research Funding - Astellas Pharma (Inst); Janssen (Inst); Novartis (Inst); Pfizer (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Sanofi
 
Johann S. De Bono
Honoraria - Astellas Pharma; AstraZeneca; Genentech/Roche; Pfizer; Sanofi
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Genentech/Roche; Sanofi
Research Funding - AstraZeneca (Inst); Genentech (Inst); Sanofi (Inst)
Patents, Royalties, Other Intellectual Property - Abiraterone Rewards to Inventors (Inst); PARP inhibitors and DNA repair defects (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Genmab; GlaxoSmithKline; Orion; Qiagen; Sanofi; Taiho Pharmaceutical; Vertex
 
Melissa Ruth Spears
Research Funding - Astellas Oncology (Inst); Janssen (Inst); Novartis (Inst); Pfizer (Inst); Sanofi (Inst)
 
Noel Clarke
No Relationships to Disclose
 
Malcolm David Mason
Honoraria - Bayer
Consulting or Advisory Role - Janssen; Sanofi
Speakers' Bureau - Sanofi
Research Funding - Ferring
 
David P. Dearnaley
Honoraria - Janssen; Sandoz; Takeda
Consulting or Advisory Role - Cadence Research and Consulting; FirstWord; Janssen; Janssen Research & Development; Sandoz; Takeda
Speakers' Bureau - Janssen; Janssen-Cilag
Patents, Royalties, Other Intellectual Property - Abiraterone acetate was developed at The Institute of Cancer Research, which therefore has a commercial interest in the development of this agent. Professor Dearnaley is on the Institute’s Rewards to Inventors list for abiraterone acetate. (Inst)
Expert Testimony - Vitality Life
Travel, Accommodations, Expenses - Janssen; Takeda
 
Alastair W S Ritchie
No Relationships to Disclose
 
J. Martin Russell
Travel, Accommodations, Expenses - Janssen-Cilag
 
Clare Gilson
No Relationships to Disclose
 
Robert J. Jones
Honoraria - Novartis; Sanofi
Research Funding - Novartis; Sanofi
 
Silke Gillessen
Consulting or Advisory Role - Active Biotech (Inst); Advanced Accelerator Applications (Inst); Astellas Pharma (Inst); Bayer; Bristol-Myers Squibb (Inst); Curevac (Inst); Dendreon; Ferring (Inst); Janssen-Cilag; MaxiVax ; Millennium; Novartis (Inst); Orion; pfizer; Roche (Inst); Sanofi
Patents, Royalties, Other Intellectual Property - Method for biomarker (WO 3752009138392 A1)
Travel, Accommodations, Expenses - Diverse Companies
Other Relationship - ESSA; Nektar; ProteoMediX
 
David Matheson
No Relationships to Disclose
 
San Aung
No Relationships to Disclose
 
Alison J. Birtle
Honoraria - Janssen-Cilag
Consulting or Advisory Role - Astellas Medivation; AstraZeneca; Bayer Schering Pharma; Janssen Oncology; Roche; Sanofi
 
Simon Chowdhury
Honoraria - GlaxoSmithKline; Novartis
Consulting or Advisory Role - Astellas Medivation; Clovis Oncology; Janssen; Pfizer; Sanofi
Speakers' Bureau - Astellas Medivation; Clovis Oncology; Janssen; Pfizer; Sanofi
Research Funding - Johnson & Johnson; Sanofi
 
Joanna Gale
No Relationships to Disclose
 
Zafar Malik
Consulting or Advisory Role - Astellas Oncology; Sanofi
Speakers' Bureau - Janssen
Research Funding - Sanofi
Travel, Accommodations, Expenses - Astellas Medivation; Bayer; Janssen
 
Joe M. O'Sullivan
No Relationships to Disclose
 
Mahesh K B Parmar
Research Funding - Astellas Medivation (Inst); Clovis Oncology (Inst); Janssen (Inst); Novartis (Inst); Pfizer (Inst); Sanofi (Inst)
 
Matthew Robert Sydes
Research Funding - Astellas Pharma; Clovis Oncology (Inst); Janssen-Cilag; Novartis; Pfizer; Sanofi